BEYOND THE GATES/FAUCI ERA

What happens next?

BLOCKBUSTER DRUGS BECOME RIP-OFFS

The unsustainability of the Gates/Fauci Big Pharma model of drug development is now plain for all to see.

It started to sound a bit dodgy when ‘Glybera’, the first gene therapy drug to be launched in Europe, was priced at $1M, and unsurprisingly, was withdrawn from the market having sold diddly-squat, see Goodbye Glybera!…